Pay in 4 interest-free payments of $5.16 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Clinical Capsules: Zepbound for Zzzs: Exploring Tirzepatide for Sleep Apnea In this episode, TRC Healthcare editor, Sara Klockars, PharmD, BCPS unpacks the newly approved use of tirzepatide (Zepbound) for obstructive sleep apnea (OSA) a first-in-class pharmacologic option for a condition long managed with devices and lifestyle changes
Focus: Maintaining consistency, preventing complacency, optimizing nutrition
FOR DIZZINESS SOURCE: DailyMed
Mounjaro and Zepbound are registered trademarks of Eli Lilly
The newer 7.2 mg dose is available for those who need additional support beyond 2.4 mg
The larger unknown risk is that tens of millions of temporary GLP-1 users develop what is a real issue for many traditionally processed food products a sudden aversion to ultra-processed flavor profiles themselves
